TrialBone marrow transplantation2017

Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial.

S Huhn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.